UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 5, 2021 4:30 P.M.
Form: S-3
CIK: 0000850261
Company Name: Sorrento Therapeutics, Inc.
File Number: 333-253646